Accuracy of Spybite Forceps When Compared to Conventional Sampling Methods
- Conditions
- Pancreatic Duct StrictureBile Duct StrictureAccuracy of Tissue Diagnosis
- Interventions
- Procedure: ERCP with cholangiopancreatoscopy
- Registration Number
- NCT01227382
- Lead Sponsor
- University of Florida
- Brief Summary
The investigators are evaluating the use of a SpyBite biopsy forceps for tissue diagnosis when compared to standard biopsy techniques.
- Detailed Description
The participants will undergo an Endoscopic Retrograde Cholangiopancreatography (ERCP) with cholangiopancreatoscopy and evaluation of a bile duct or pancreatic duct stricture with three different types of techniques for biopsy: SpyBite biopsy forceps, cytology brush and RJ3biopsy forceps.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 26
- Subjects is 18 years or older
- Scheduled to undergo Endoscopic Retrograde Cholangiopancreatography (ERCP) wiht cholangioscopy and/or pancreatoscopy at the University of Florida Gainesville Florida as medically indicated.
- Lesion of the pancreatobiliary system that requires tissue sampling as medically indicated
- Subject myst be able to give informed consent
- Any contraindication to Endoscopic Retrograde Cholangiopancreatography (ERCP)
- The subject is unable to give informed consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description ERCP with Cholangiopancreatoscopy ERCP with cholangiopancreatoscopy The subjects who have been scheduled for an Endoscopic Retrograde Cholangiopancreatography (ERCP) with Cholangiopancreatoscopy for evaluation of a bile duct or pancreatic duct stricture sampling.
- Primary Outcome Measures
Name Time Method Percentage of Participants With Accurate Diagnoses of Cancer up to 7 days after the procedure The diagnostic accuracy of the Spybite Biopsy forceps was compared to both the cytology brush and the RJ3 biopsy forceps sampling of any stricture or biliary lesions found on Endoscopic Retrograde Cholangiopancreatography (ERCP). All three methods were used at baseline to obtain a sample for the determination of cancer vs. no cancer.
- Secondary Outcome Measures
Name Time Method Procedure Technical Success day 1 The procedure technical success was defined when all of the following criteria were met: Successful advancement of the cholangioscope to the desired target, adequate cholangioscopic visualization of the area of interest, and successful applications of of all sampling maneuvers with visible tissue seen macroscopically when obtaining mini forceps and standard forceps biopsy samples.
Total Procedure Time 120 minutes The total time to perform ERCP
Total Cholangioscopy Time 60 minutes This is the total time it takes for the dye to be performed during the ERCP.
Adverse Events 24 hours Adverse events were prospectively evaluated at the end of the procedure, at discharge from the endoscopy unit, and by telephone call 24 hours post procedure. Adverse events were defined and graded using the 2010 American Society for Gastrointestinal Endoscopy consensus criteria.
Sampling Times for Each Device 15 minutes The sampling time of the Spybite Biopsy forceps was compared to both the cytology brush and the RJ3 biopsy forceps of any stricture or biliary lesions found on Endoscopic Retrograde Cholangiopancreatography (ERCP).
Cholangioscopy Visualization Time 30 minutes The portion of the total ERCP time spent on Cholangioscopy visualization.
Trial Locations
- Locations (1)
Shands at UF Ensopcopy
🇺🇸Gainesville, Florida, United States